AN2 Therapeutics Presents Clinical Data for Epetraborole

AN2 Therapeutics unveiled new clinical and translational data supporting the development of Epetraborole for treating polycythemia vera during the SOHO 2026 Annual Meeting.

31 Aug, 22:23 — 31 Aug, 22:23

Post Share

Sources

Showing 1 of 1 sources

morningstar8h ago

AN2 Therapeutics Presents Clinical and Translational Data Supporting Development of Epetraborole for Polycythemia Vera at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting - Morningstar

AN2 Therapeutics Presents Clinical and Translational Data Supporting Development of Epetraborole for Polycythemia Vera at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting Morningstar

Read full article →

AN2 Therapeutics Presents Clinical Data for Epetraborole

Sources

AN2 Therapeutics Presents Clinical and Translational Data Supporting Development of Epetraborole for Polycythemia Vera at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting - Morningstar

Related Stories

Tim Cook Steps Down as Apple CEO; John Ternus Takes Helm

Shein Shares Plunge in Disappointing Hong Kong Stock Market Debut

South Korea Reports Record August Export Surge Driven by Semiconductor Demand

South Korean and Turkish Defense Firms Climb Global Industry Rankings